|
N=(192)
|
N=(64)
|
|
N/Mean
|
%/SD
|
N/Mean
|
%/SD
|
p-value
|
|
PE-related Clinical Outcomes during the 90-day follow-up period
|
| Recurrent VTE |
9 |
4.7% |
2 |
3.1% |
0.5935 |
|
Time to first VTE, days
|
47.6 |
24.6 |
29.5 |
26.2 |
0.3763 |
| Major Bleeding |
2 |
1.0% |
0 |
0.0% |
0.4124 |
|
Time to first Major Bleeding, days
|
5.00 |
2.8 |
|
|
|
| Death |
3 |
1.6% |
0 |
0.0% |
0.3145 |
|
Time to Death, days
|
35.33 |
30.4 |
|
|
|
|
90-day Follow-up Diagnostic tests
|
| CTA |
63 |
32.8% |
17 |
26.6% |
0.3502 |
| ECHO |
14 |
7.3% |
2 |
3.1% |
0.233 |
| VQ Scan |
6 |
3.1% |
1 |
1.6% |
0.5068 |
| Venous Doppler Ultrasound |
56 |
29.2% |
16 |
25.0% |
0.5208 |